Managing Active Iupus Nephritis During COVID-19 Pandemic

India is seeing a rapid rise in coronavirus disease-2019 (COVID-19). Immunosuppression is a possible risk factor for severe COVID-19, although their exact interaction is unclear. A total of 13 cases with active lupus nephritis (LN, with or without extra-renal manifestations) were managed with intens...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharati, Joyita, Rathi, Manish, Ramachandran, Raja, Sharma, Aman, Nada, Ritambhra, Kohli, Harbir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443088/
https://www.ncbi.nlm.nih.gov/pubmed/34584357
http://dx.doi.org/10.4103/ijn.IJN_301_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443088/
https://www.ncbi.nlm.nih.gov/pubmed/34584357
http://dx.doi.org/10.4103/ijn.IJN_301_20

Ejemplares similares